Clinical Trial

Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 8, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a prospective, single-center, observational study. In this study, we aim to evaluate the clinical outcome and cost-effectiveness of different treatments of lower extremity arterial occlusive disease. It is expected to include about 400 patients diagnosed with lower extremity arterial occlusive disease in our center from July 2024 to July 2026. All enrolled patients will be followed for three years. All patients diagnosed with arteriosclerosis obliterans (ASO) and all treatment techniques were included in this study. The primary outcomes include the Efficacy and Safety End Points of each techniques.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-26; most recent amendment 2025-08-05.
Trial Details
NCT Number NCT06485622
Lead Sponsor First Affiliated Hospital, Sun Yat-Sen University
Conditions Arteriosclerosis Obliterans
Enrollment 400 participants
Start Date 2024-07-01
Primary Completion 2026-07 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2025-08-08